Header Logo

Connection

Marc Fisher to Clinical Trials as Topic

This is a "connection" page, showing publications Marc Fisher has written about Clinical Trials as Topic.
Connection Strength

2.044
  1. Fisher M, Wakhloo A. Dawning of a new era for acute stroke therapy. Stroke. 2015 Jun; 46(6):1438-9.
    View in: PubMed
    Score: 0.489
  2. Fisher M, Hanley DF, Howard G, Jauch EC, Warach S. Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke. 2007 Feb; 38(2):245-8.
    View in: PubMed
    Score: 0.274
  3. Fisher M, Henninger N. Translational research in stroke: taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trials. Curr Neurol Neurosci Rep. 2007 Jan; 7(1):35-41.
    View in: PubMed
    Score: 0.274
  4. Fisher M, Davalos A. The MATCH study results in the context of secondary stroke prevention. Stroke. 2004 Nov; 35(11):2609.
    View in: PubMed
    Score: 0.235
  5. Lyden P, Weymer S, Coffey C, Cudkowicz M, Berg S, O'Brien S, Fisher M, Haley EC, Khatri P, Saver J, Levine S, Levy H, Rymer M, Wechsler L, Jadhav A, McNeil E, Waddy S, Pryor K. Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection. Stroke. 2016 12; 47(12):2979-2985.
    View in: PubMed
    Score: 0.135
  6. Fisher M. New approaches to neuroprotective drug development. Stroke. 2011 Jan; 42(1 Suppl):S24-7.
    View in: PubMed
    Score: 0.090
  7. Sicard KM, Fisher M. Emerging drugs for acute ischemic stroke. Expert Opin Emerg Drugs. 2009 Mar; 14(1):33-42.
    View in: PubMed
    Score: 0.080
  8. Fisher M. The ischemic penumbra: a new opportunity for neuroprotection. Cerebrovasc Dis. 2006; 21 Suppl 2:64-70.
    View in: PubMed
    Score: 0.065
  9. Fisher M. Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist. Arch Neurol. 2006 Jan; 63(1):20-4.
    View in: PubMed
    Score: 0.064
  10. Fisher M, Tatlisumak T. Use of animal models has not contributed to development of acute stroke therapies: con. Stroke. 2005 Oct; 36(10):2324-5.
    View in: PubMed
    Score: 0.062
  11. Furlan AJ, Fisher M. Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke. 2005 Feb; 36(2):398-9.
    View in: PubMed
    Score: 0.060
  12. Duong TQ, Fisher M. Applications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke. Curr Atheroscler Rep. 2004 Jul; 6(4):267-73.
    View in: PubMed
    Score: 0.058
  13. Fisher M. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke. 2003 Jun; 34(6):1539-46.
    View in: PubMed
    Score: 0.053
  14. Fisher M, Brott TG. Emerging therapies for acute ischemic stroke: new therapies on trial. Stroke. 2003 Feb; 34(2):359-61.
    View in: PubMed
    Score: 0.052
  15. Fisher M. Ongoing trials and future directions for acute ischemic stroke treatment. Adv Neurol. 2003; 92:401-8.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.